prevention of comorbidities/associated diseases – what is known today | luigi naldi, md | italy
Published 2 years ago • 128 plays • Length 13:37Download video MP4
Download video MP3
Similar videos
-
19:44
the science behind disease memory, and what is missing | liv eidsmo, md, phd | denmark
-
52:35
npf webinar: getting to the heart of comorbidities
-
9:10
early intervention with secukinumab may affect the establishment of tissue memory in psoriasis
-
20:03
comorbidities of psoriasis across the world | silvia fernandez barrio | argentina
-
33:10
the emerging role of the immune microenvironment in hematological malignancies
-
6:08
defining paradoxical psoriasis and deep tissue immune cell profiling | david croitoru | canada
-
36:46
biomarkers in the long-term management of psoriasis | catherine smith, md | united kingdom
-
1:10:08
introduction: personalized medicine in psoriasis with a focus on stratification and biomarkers
-
1:01:11
how to organize our psoriasis clinics in the future
-
27:58
considering comorbidities in treatment planning | andrew blauvelt, md, mba | united states
-
13:02
personalized medicine in the treatment of psoriasis | peter van de kerkhof, md, phd | netherlands
-
28:06
management of co-morbidities: avoiding infectious complications
-
18:10
interactions between skin inflammatory diseases & covid: lessons from genomic epidemiology studies
-
4:42
psoriasis and comorbidities: what dermatologists need to know
-
7:23
insight into pathologic epidermal-immune interactions in psoriasis
-
19:46
immunology (part 1)
-
34:26
evaluation of biologic therapies in psoriasis: what is the evidence beyond clinical trials?